Active: new fund Oct 2025 Verified 5 Nov 2026
4BIO Capital
London-based venture capital firm, trading name of 4BIO Partners LLP, that invests in early-stage companies developing advanced therapies such as cell and gene therapy, RNA-based therapy and the microbiome.
- Type
- VC firm
- Location
- London, United Kingdom
- Stages
- Seed, Series A
- Backs
- Biotech and pharma
- Sectors
- Healthtech and life sciences, Biotech
- Website
- www.4biocapital.com
Contacts on file
For 4BIO Capital, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
Cytospire TherapeuticsCloverleaf BioAptadir TherapeuticsUndecimal BioEstuary Biotherapeutics
Sources
- www.4biocapital.com/
- www.4biocapital.com/team
- www.4biocapital.com/about
- www.4biocapital.com/contacts
- www.4biocapital.com/news
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 19 lists
Biotech investors in London (42)Active startup investors in the UK (73)Biotech investors in the UK (92)Healthtech investors in London (113)Venture capital firms in London (149)Series A biotech investors (153)Series A investors in the UK (154)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Startup investors in London (239)Seed investors in the UK (295)Seed biotech investors (300)Series A healthtech investors (401)Startup investors in the UK (416)Biotech investors (484)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)